ProfileGDS4284 / 1555725_a_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 19% 34% 36% 29% 42% 10% 22% 16% 33% 38% 43% 38% 33% 16% 40% 20% 30% 3% 31% 27% 8% 24% 33% 27% 30% 13% 15% 31% 36% 2% 26% 33% 49% 43% 39% 33% 33% 23% 23% 14% 6% 42% 36% 3% 5% 14% 35% 42% 68% 45% 29% 39% 2% 7% 27% 31% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control32.490319
GSM687648Patient 402 control91.65734
GSM687653Patient 403 control100.13136
GSM687658Patient 404 control76.944229
GSM687663Patient 411 control157.17642
GSM687668Patient 422 control16.042510
GSM687673Patient 424 control52.180922
GSM687678Patient 425 control30.77116
GSM687683Patient 427 control102.3533
GSM687688Patient 428 control122.3138
GSM687695Patient 441 control233.40443
GSM687699Patient 443 control150.02538
GSM687704Patient 444 control95.197133
GSM687707Patient 448 control35.640216
GSM687712Patient 449 control134.38940
GSM687719Patient 450 control50.621220
GSM687724Patient 451 control95.070530
GSM687728Patient 452 control8.178613
GSM687646Patient 401 treated 24h83.108331
GSM687649Patient 402 treated 24h61.132627
GSM687665Patient 411 treated 24h16.27098
GSM687651Patient 402 treated 4 weeks58.208724
GSM687667Patient 411 treated 4 weeks97.202433
GSM687670Patient 422 treated 24h68.498327
GSM687671Patient 422 treated 4 weeks75.43630
GSM687654Patient 403 treated 24h18.719813
GSM687675Patient 424 treated 24h29.691115
GSM687685Patient 427 treated 24h86.089731
GSM687656Patient 403 treated 4 weeks96.241436
GSM687677Patient 424 treated 4 weeks5.817222
GSM687687Patient 427 treated 4 weeks54.120226
GSM687692Patient 428 treated 4h93.315533
GSM687716Patient 449 treated 4h193.83749
GSM687722Patient 450 treated 4h185.65743
GSM687680Patient 425 treated 24h126.75139
GSM687690Patient 428 treated 24h90.34433
GSM687700Patient 443 treated 24h140.56533
GSM687705Patient 444 treated 24h46.336123
GSM687714Patient 449 treated 24h46.130523
GSM687721Patient 450 treated 24h30.745914
GSM687682Patient 425 treated 4 weeks10.05946
GSM687694Patient 428 treated 4 weeks130.92142
GSM687702Patient 443 treated 4 weeks121.89936
GSM687718Patient 449 treated 4 weeks7.421153
GSM687723Patient 450 treated 4 weeks11.34475
GSM687661Patient 404 treated 4h25.66914
GSM687710Patient 448 treated 4h101.3635
GSM687726Patient 451 treated 4h170.26342
GSM687730Patient 452 treated 4h766.00368
GSM687660Patient 404 treated 24h208.5145
GSM687697Patient 441 treated 24h104.32829
GSM687709Patient 448 treated 24h140.41139
GSM687725Patient 451 treated 24h8.154132
GSM687729Patient 452 treated 24h21.72987
GSM687727Patient 451 treated 4 weeks80.578727
GSM687731Patient 452 treated 4 weeks98.217331